Novartis Launches Europe’s First Specialized Viral Vector Production Facility in Slovenia
Novartis has unveiled its first dedicated viral vector production facility in Slovenia, marking a bold leap forward in its European ...
Read moreNovartis has unveiled its first dedicated viral vector production facility in Slovenia, marking a bold leap forward in its European ...
Read moreThe Sandoz family has impressively raised CHF 2.6 billion by selling shares in Novartis, highlighting a surge of investor enthusiasm ...
Read more© 2024 EUROP.INFO - Copyright for syndicated content belongs to the linked Source.
© 2024 EUROP.INFO - Copyright for syndicated content belongs to the linked Source.